ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

YU-CHENG JEFFREY CHEN M.D.

At A Glance: This Prescriber in 2012

Specialist

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

12,664Medicare Part D Prescriptions Filled, Including Refills

Rank: 9 out of 300

$710K Total Retail Price of All Prescriptions

Rank: 21 out of 300

814 Patients Receiving at Least One Drug in Part D
83%Patients 65 Years and Older
32% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Louisiana
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

N/A

Risky Drugs to Seniors

0% of this provider’s 10,883 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 4%.

Brand Name Drugs

27% of this provider’s prescriptions were for brand-name drugs, compared to an average of 28%.

Prescription Price

$56 was the average price of a prescription from this provider, compared to $81 among peers.

Prescriptions per Patient

16 is the average number of prescriptions (including refills) per patient, compared to an average of 10.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Louisiana
CARVEDILOL 770 609 1 12
AMLODIPINE BESYLATE 727 632 2 2
FUROSEMIDE 699 577 3 3
WARFARIN SODIUM 579 510 4 10
SIMVASTATIN 498 381 5 5
DIGOXIN 492 453 6 39
METOPROLOL SUCCINATE 461 420 7 6
CLOPIDOGREL 448 371 8 18
ENALAPRIL MALEATE 443 395 9 86
LISINOPRIL 397 339 10 4
POTASSIUM CHLORIDE 355 314 11 22
AMLODIPINE BESYLATE-BENAZEPRIL 355 295 11 52
ISOSORBIDE MONONITRATE ER 342 266 13 32
PLAVIX 299 262 14 24
PRADAXA 213 209 15 108
DILTIAZEM 24HR ER 184 177 16 173
ATORVASTATIN CALCIUM 176 149 17 14
MULTAQ 172 161 18 177
METOPROLOL TARTRATE 171 137 19 13
ATENOLOL 156 126 20 31
LOSARTAN POTASSIUM 144 118 21 29
CRESTOR 143 116 22 26
BENAZEPRIL HCL 137 122 23 73
VYTORIN 136 132 24 154
DIOVAN HCT 133 117 25 94
LISINOPRIL-HYDROCHLOROTHIAZIDE 131 109 26 64
LOSARTAN-HYDROCHLOROTHIAZIDE 128 106 27 97
DIOVAN 123 112 28 46
HYDROCHLOROTHIAZIDE 106 94 29 20
BYSTOLIC 105 91 30 59
DILTIAZEM 24HR CD 103 91 31 250
TRICOR 102 78 32 161
RANEXA 102 64 32 124
SPIRONOLACTONE 101 93 34 92
NIASPAN 97 91 35 183
NITROSTAT 94 61 36 157
RAMIPRIL 86 66 37 63
ZETIA 85 66 38 109
PROPAFENONE HCL 84 72 39 166
CLONIDINE HCL 84 82 39 50
PRAVASTATIN SODIUM 83 61 41 15
SOTALOL 83 78 41 133
NEXIUM 80 58 43 17
OMEPRAZOLE 72 59 44 11
LIPITOR 66 62 45 115
CILOSTAZOL 64 62 46 182
TRILIPIX 60 56 47 253
FENOFIBRATE 60 49 47 98
KLOR-CON M20 51 50 49 89
LANOXIN 51 51 49 439
KLOR-CON M10 50 50 51 311
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Aug. 29, 2011.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.